Search Tag: Masimo

ICU Management

New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward

2021 17 May

Researchers Found That Use of Patient SafetyNet with Masimo SET® Pulse Oximetry and Acoustic Repsiratory Rate (RRa®) Monitoring Reduced Nursing Workload Related to Postoperative Respiratory Assessment by More Than 60% NEUCHATEL, Switzerland--(BUSINESS WIRE)--  Masimo  (NASDAQ: MASI) announced today the findings of a study published in the Journal... Read more

ICU Management

Spacelabs Healthcare Partners With Masimo to Bring Advanced Measurements

2021 13 May

SNOQUALMIE, Wash.--(BUSINESS WIRE)--  Spacelabs Healthcare ®, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”), and  Masimo  today announced that they have extended their partnership in patient monitoring to integrate SET® pulse oximetry, NomoLine® capnography, rainbow SET® Pulse CO-Oximetry, SedLine® brain function monitoring, and... Read more

ICU Management

Study Investigates the Ability of Masimo O3® to Monitor Septic Shock Patients & Predict Mortality

2021 05 May

Researchers Found That O3 May Help Clinicians Rapidly Assess Circulatory Status in Patients Experiencing Septic Shock and Have Prognostic Value in Mortality Prediction NEUCHATEL, Switzerland--(BUSINESS WIRE)--  Masimo  (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr.... Read more

ICU Management

Masimo Announces FDA Clearance of Radius PCG™ for Root® Patient Monitoring & Connectivity Platform

2021 12 Apr

Masimo  (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance. Radius PCG connects with the Root® Patient Monitoring and Connectivity Platform to provide seamless, tetherless mainstream capnography for patients of all ages. Radius PCG joins the growing... Read more

ICU Management

Masimo to Present in 20th Annual Needham Healthcare Conference

2021 07 Apr

 Masimo  (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at  www.masimo.com . A replay of the webcast will be available following the live presentation. Read more

ICU Management

Study Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients

2021 06 Apr

Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 Masimo  (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation... Read more

ICU Management

Study Investigates Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®

2021 29 Mar

Masimo  (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo Rad-G™, a rugged, handheld device, on malnourished, hospitalized children... Read more

ICU Management

Sri Lankan Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry

2021 22 Mar

Masimo  today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo SET® pulse oximetry. 1  The authors concluded that pulse oximetry... Read more

ICU Management

FDA Clearance for Masimo O3® Regional Oximetry for Extended Use in Cerebral & Somatic Applications

2020 31 Aug

Masimo  today announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. With this FDA clearance, O3 is now indicated for use in both cerebral and somatic... Read more

ICU Management

New Studies Investigate the Accuracy of Masimo SpHb® on Neonates

2020 19 Aug

Masimo  today announced that in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb® (noninvasive, continuous hemoglobin monitoring) on neonatal patients concluded that the technology “offers reliable Hb [hemoglobin] values, which are comparable with the more traditional tHb [invasive venous blood... Read more